AXGN
HEALTHYAxogen, Inc.
CIK: 0000805928
Last activity: Dec 16, 2025
Financial Metrics
As of Dec 31, 2024 (10-K)
Insider Roster (10 total, 10 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| DALE MICHAEL D Chief Executive Officer | 0 | 2 | -$2.67M | 63,537 shares $1.91M |
| JOHNSON JOHN DIRECTOR | 0 | 4 | -$1.39M | Holdings: - Value: - |
| Weiler Kathy Johnson DIRECTOR | 0 | 3 | -$1.38M | 6,580 shares $194K |
| Wendell Amy McBride DIRECTOR | 0 | 3 | -$1.28M | 112,074 shares $3.29M |
| Hartley Lindsey Marie CFO | 0 | 3 | -$896K | 31,376 shares $937K |
| TYNDALL JOSEPH A. DIRECTOR | 0 | 2 | -$778K | 10,860 shares $336K |
| Began Marc A EVP & General Counsel | 0 | 2 | -$686K | 18,285 shares $549K |
| THOMAS PAUL DIRECTOR | 0 | 1 | -$634K | 13,528 shares $401K |
| DeVinney Erick Wayne Chief Innovation Officer | 0 | 1 | -$609K | 241,132 shares $7.53M |
| Kemp Jens Chief Marketing Officer | 0 | 1 | -$255K | 46,030 shares $1.44M |
Recent Transactions
21,825 shares @ $29.55
$645K
Dec 16, 2025
20,436 shares @ $29.31
$599K
Dec 16, 2025
18,248 shares @ $29.55
$539K
Dec 16, 2025
18,248 shares @ $29.31
$535K
Dec 16, 2025
6,580 shares @ $29.55
$194K
Dec 16, 2025
5,000 shares @ $29.31
$147K
Dec 16, 2025
14,812 shares @ $29.86
$442K
Dec 15, 2025
13,222 shares @ $30.00
$397K
Dec 11, 2025
25,000 shares @ $30.00
$750K
Dec 10, 2025
61,463 shares @ $31.21
$1.92M
Dec 9, 2025
21,399 shares @ $29.61
$634K
Dec 9, 2025
19,517 shares @ $31.21
$609K
Dec 9, 2025
14,248 shares @ $30.98
$441K
Dec 9, 2025
13,141 shares @ $29.98
$394K
Dec 9, 2025
10,860 shares @ $30.98
$336K
Dec 9, 2025
9,278 shares @ $31.21
$290K
Dec 9, 2025
8,545 shares @ $29.98
$256K
Dec 9, 2025
8,156 shares @ $31.21
$255K
Dec 9, 2025
11,891 shares @ $31.22
$371K
Dec 8, 2025
11,802 shares @ $31.26
$369K
Dec 8, 2025
11,533 shares @ $31.56
$364K
Dec 8, 2025
2,854 shares @ $31.56
$90K
Dec 8, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.